The Dana-Farber Cancer Institute, an affiliate of the Harvard Medical School, will retract or correct dozens of papers by four top cancer researchers following the results of a data falsification investigation.

Six papers will be retracted entirely, and 31 will have corrections issued, per the results of an investigation started after allegations of data manipulation against the institute’s president and CEO, Laurie H. Glimcher, and three other researchers.